title: Cytopathology in Austria.
abstract: Cervical cancer screening developed rapidly during the 1970s. Today, approximately 1.5 million smears are taken annually, so 50% of the target population are screened every year, 30% are cytologically underserved (24% never had a smears, 6% only once). This figure correlates with the fact that there are still 30% deaths from cervical cancer compared with 1960. Since 1998 a voluntary quality assurance programme was introduced by the Austrian Society of Cytology, based on comparison of results reported from participating laboratories.
authors.affiliation: Austrian Society of Cytology Department of Gynaecopathology and Cytology, University of Vienna, Vienna, Austria. gerhard.breitenecker@univie.ac.at
authors.forename: G
authors.initials: G
authors.lastname: Breitenecker
authors.forename: H P
authors.initials: HP
authors.lastname: Dinges
authors.forename: P
authors.initials: P
authors.lastname: Regitnig
authors.forename: H
authors.initials: H
authors.lastname: Wiener
authors.forename: Ch
authors.initials: Ch
authors.lastname: Vutuc
mesh_terms: D000328:Adult; D000368:Aged; D001317:Austria; D001707:Biopsy, Needle; D003625:Data Collection; D005260:Female; D006801:Humans; D015994:Incidence; D008403:Mass Screening; D008875:Middle Aged; D009313:National Health Programs; D015397:Program Evaluation; D011786:Quality Control; D017010:Reminder Systems; D012680:Sensitivity and Specificity; D002583:Uterine Cervical Neoplasms / Q000453:epidemiology* / Q000401:mortality / Q000473:pathology*; D014626:Vaginal Smears; D014932:Women's Health Services